SCHEMBL7948147

SCHEMBL7948147

CO[C@@H]1[C@@H](Oc2ccc([N+](=O)[O-])cc2)O[C@@H](C)[C@H]2OC(C)(C)O[C@@H]12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.38
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 2/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
THRB P10828 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
APP P05067 1/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TLR9 Q9NR96 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
GAA P10253 1/20 0.32
HSPB1 P04792 1/20 0.32
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957913 0.84 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2LMNATP53CYP3A4
SCHEMBL7957722 0.84 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2LMNATP53CYP3A4
SCHEMBL7955324 0.83 NT5E (0.43) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL6758197 0.82 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2LMNATP53CYP3A4
SCHEMBL7962155 0.77 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2LMNATP53CYP3A4
SCHEMBL7957974 0.77 ALDH1A1 (0.41) ALDH1A1MAPTKDM4EHTT
SCHEMBL6817377 0.77 CA12 (0.37) ALDH1A1SMN1; SMN2LMNATP53CYP3A4
SCHEMBL2021394 0.76 HTT (0.45) ALDH1A1SMN1; SMN2LMNATP53CYP3A4
SCHEMBL2021396 0.76 HTT (0.45) ALDH1A1SMN1; SMN2LMNATP53CYP3A4
SCHEMBL19718604 0.76 HTT (0.45) ALDH1A1SMN1; SMN2LMNATP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271342-B1 SERUM STABILITY; FOR TUMOR THERAPY BAYER AKTIENGESELLSCHAFT (DE) 2001-08-07 US disclosed
EP-0906313-A1 CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT Merck & Co., Inc. (US) 1999-04-07 EP disclosed
CN-1185786-A Sugar-modified cytostatics BAYER AG (DE) 1998-06-24 CN disclosed
WO-1997040048-A1 CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT MERCK & CO., INC. (US) 1997-10-30 WO disclosed